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Nitric oxideTo investigate the role of oxidative stress and/or mitochondrial impairment in the occurrence of acute kidney
injury (AKI) during sepsis, we developed a sepsis-induced in vitromodel using proximal tubular epithelial cells
exposed to a bacterial endotoxin (lipopolysaccharide, LPS). This investigation has provided key features on the
relationship between oxidative stress and mitochondrial respiratory chain activity defects.
LPS treatment resulted in an increase in the expression of inducible nitric oxide synthase (iNOS) and NADPH
oxidase 4 (NOX-4), suggesting the cytosolic overexpression of nitric oxide and superoxide anion, the primary
reactive nitrogen species (RNS) and reactive oxygen species (ROS). This oxidant state seemed to interrupt mito-
chondrial oxidative phosphorylation by reducing cytochrome c oxidase activity. As a consequence, disruptions
in the electron transport and the proton pumping across the mitochondrial inner membrane occurred, leading
to a decrease of the mitochondrial membrane potential, a release of apoptotic-inducing factors and a depletion
of adenosine triphosphate. Interestingly, after being targeted by RNS and ROS, mitochondria became in turn pro-
ducer of ROS, thus contributing to increase the mitochondrial dysfunction.
The role of oxidants in mitochondrial dysfunction was further conﬁrmed by the use of iNOS inhibitors or antiox-
idants that preserve cytochrome c oxidase activity and prevent mitochondrial membrane potential dissipation.
These results suggest that sepsis-induced AKI should not only be regarded as failure of energy status but also
as an integrated response, including transcriptional events, ROS signaling, mitochondrial activity and metabolic
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Sepsis is a very complex clinical condition characterized by stimula-
tion of a systemic inﬂammatory response related to an infection [1,2].
This process often leads to widespread tissue injury and multiple
organ dysfunction [3]. In particular, the development of acute kidney
injury (AKI) is a risk factor for mortality in septic patients [4,5].The mechanisms leading to AKI are extremely complex and still re-
main controversial. It was long thought that microvascular dysfunction
whose net effect is a failure of oxygen delivery was likely to alter renal
function at the cellular level [6]. This tissue hypoxia paradigm has
been challenged by recent studies revealing that the hemodynamic
mechanism might not be relevant in the pathophysiology of AKI [7,8].
It seems that the kidney is more challenged by impairment of cellular
oxygen utilization rather than inadequate oxygen delivery [8–10]. This
hypothesis has been corroborated in our previous work in which we
have shown the incapacity of renal tubular epithelial (HK-2) cells to
use adequately the available oxygen under bacterial endotoxin simula-
tion [11].
Renal tubular epithelium seems to be no longer a passive victim of
hypoxic injury [12]. Increasing number of studies suggest that it is a
major site of oxidative stress, and that overproduction of reactive nitro-
gen species (RNS) and reactive oxygen species (ROS) may be important
contributors in themechanism of kidney injury [13–15]. These oxidants
can react with cellular components, such as DNA, proteins and lipids,
leading to their degradation and thereby accelerating the loss of tubular
epithelium function [16,17]. However, as these studies are based on
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lial cells from side effects of renal vasoconstriction and peritubular cap-
illary hypoperfusion.
In addition to oxidative stress, mitochondrial abnormalities have
been recognized within in vivo and in vitromodels. Animal models of
sepsis, using either the bacterial endotoxin lipopolysaccharide (LPS)
or cecal ligation and puncture as stress inducers, mainly focused
on metabolic changes occurring at the level of oxidative phosphory-
lation. In LPS-treated rats, cytochrome c oxidase and adenosine
triphosphate (ATP) synthase were down-regulated both at the tran-
script and protein level within 48 h after treatment [18]. This inhibi-
tion of cytochrome c oxidase was also observed in severe sepsis and
had the characteristic of being irreversible [19,20]. In another case of
endotoxic shock, the LPS treatment resulted in a 70% decrease of ATP
levels after 8 h, a critical time for which about 30% of the animals
were dead [21]. Moreover, several studies have pointed out that
antioxidant treatment reversed cell mitochondrial dysfunction in
sepsis animal models but there is still uncertainty concerning the
involvement of ROS and RNS [22,23].
Despite this increasing evidence of oxidative stress and mitochon-
drial injury being important in the development of sepsis-induced
AKI, it remains unclear if mitochondrial dysfunction is the primary
event that leads to oxidative stress and further mitochondrial impair-
ment, or if the oxidative stress initiates mitochondrial dysfunction
with a subsequent RNS and ROS release [24,25]. In addition, the cellular
source of ROS and RNS generation is still unclear. Indeed, radical species
were once thought to originate almost entirely frommitochondrial me-
tabolism but recent data focused on the crucial role of cellular enzymes,
such as NADPH oxidases, as important sources of ROS [26]. This empha-
sizes that the mechanisms underlying ROS, RNS production and mito-
chondrial dysfunction have not been yet fully elucidated. To highlight
this phenomenon, we developed a sepsis-induced in vitromodel using
human proximal tubular epithelial (HK-2) cells exposed to LPS. This
investigation has provided key features on the relationship between
oxidative stress and mitochondrial respiratory chain activity defects.
2. Materials and methods
2.1. Cell culture and treatment
HK-2 cells, an immortalized proximal tubular epithelial cell line from
normal adult human kidney [27], were cultured in DMEM (Lonza,
Switzerland) supplemented with 10% heat-inactivated FBS (Biochrom,
Germany), 2 mM L-glutamine, 100 U/ml penicillin and 100 μg/ml strep-
tomycin (Invitrogen, Belgium). Cells were grown to approximately 70%
conﬂuence at 37 °C in a humidiﬁed 5% CO2 incubator.
To determine the toxic effects of LPS on mitochondrial functionality
of HK-2 cells, they were incubated with fresh medium containing
1 μg/ml LPS from Escherichia coli 055:B5 (Sigma Aldrich, Belgium) for
different incubation times. The role of oxidants was investigated by
incubating cells for 6 h with fresh medium containing 1 μg/ml LPS and
different types of antioxidants (all from Enzo Life Science, Belgium):
10 μM L-NMMA, 10 μM 1400W, 1 μM diphenylene iodonium (DPI),
100 μM L-glutathione (GSH), or 10 μM ebselen (EBS). For each experi-
ment, cells were incubated without any endotoxin or drugs and taken
as control groups.
2.2. Measurement of NO2
−/NO3
− in culture media
To investigate the implication of nitric oxide radical (•NO) in the
mechanism by which LPS induced HK-2 cell stress, its production was
controlled. At the end of the LPS treatment of HK-2 cells, the culture su-
pernatants (without red phenol) were collected and the concentrations
of NO2−/NO3−were quantiﬁed by using the Total Nitric Oxide Detection
Kit (Enzo Life Sciences, Belgium). This assay is based on the enzymatic
reduction of NO3− to NO2− by nitrate reductase. The reaction wasfollowed by the colorimetric detection of NO2− as a colored azo dye,
product of the Griess reaction that absorbs visible light at 540 nm. The
total •NO released by cells was determined by subtracting NO2−/NO3−
levels initially present in the media from the levels determined after
incubation.2.3. RT-PCR for iNOS induction
Inducible nitric oxide synthase (iNOS) is one of the major sources of
•NO by catalyzing L-arginine. Its messenger RNA (mRNA) levels was es-
timate by RT-PCR experiments. Total RNA was puriﬁed from HK-2 cells
using RNeasy Mini Kit (Quiagen, Canada) as described by the manufac-
turer and quantiﬁed by its UV absorbance. RNA was then reverse
transcribed using the High Capacity cDNA Reverse Transcription Kit
(Applied Biosystems, Canada). Speciﬁc primers from TaqMan Gene
Expression Assays (Applied Biosystems, Canada) for iNOS and actin
were used for ampliﬁcation of cDNA using TaqMan Universal Master
Mix II (Applied Biosystems, Canada). Ampliﬁcation was performed
by successive 40 cycles of temperature (95 °C, 15 s; 60 °C, 60 s) in a
temperature cycler (DNA Thermal Cycler, Perkin-Elmer). The primers
used were human β-actin (ACTB, Hs99999903_m1) and human
iNOS (NOS2, Hs01075529_m1). The LPS-stimulated iNOS expression
relative actin was reported as the fold increase compared to that of
non-stimulated.2.4. Quantiﬁcation of O2•
− production
As ROS are possible mediators of cell alterations, we considered the
possible implication of superoxide anion radicals (O2•−). After LPS treat-
ment, the concentration of O2•− in HK-2 cells was determined by the
spectrophotometric method based on the reduction of nitroblue tetrazo-
lium (NBT) to formazan in the presence of O2•− [28,29]. In a 24-well plate
containing HK-2 cells treated with LPS, 200 μl of 0.2% NBT solution was
added for 1 h at 37 °C. After incubation, cells were washed twice with
prewarmed PBS, then oncewithmethanol in order to completely remove
the extracellular formazan. NBT deposits inside cells were then dissolved
with 2 M KOH and DMSO and the resulting color reaction was measured
spectrophotometrically on microplate reader at 650 nm (Multiskan
Microplate Reader, Thermo scientiﬁc, Belgium).2.5. NOX-4 western blot analysis
NADPHoxidase 4 (NOX-4) is a potent source of O2•− in kidney [30]. Its
expression in HK-2 cells during LPS treatment was detected by western
blot experiments. Cellular preparations were homogenized in lysis buffer
containing a mixture of protease and phosphatase inhibitors, 150 mM
NaCl, 20 mM Tris, 10% glycerol, 5 mM EGTA, 5 mM EDTA, 1% Triton
X-100, 0.1% SDS, and 1% sodium deoxycholate (all chemicals from
Sigma-Aldrich, Canada). Samples were centrifuged at 14000 rpm, 4 °C
for 10 min and the supernatant protein concentrations were determined
using the BCA protein assay kit (Pierce, Canada) following the
manufacturer's instructions. Samples were subjected to DTT and glycerol,
boiled for 5 min and stored at−20 °C until analysis.
20 μg of proteins per well was separated on 7.5% SDS-PAGE gel and
transferred to nitrocellulose membranes (materials were from Bio-Rad
Laboratories — Clinical Diagnostics, Canada). After 1 h of blocking in TBS
containing 0.1% Tween and 5% BSA, membranes were incubated over-
night at 4 °C with primary antibodies: 0.4 μg/ml of goat polyclonal anti-
NOX-4 antibody (Santa Cruz Biotechnology, sc-55142) and 1/20000 dilu-
tion ofmouse anti-actin (Millipore,MAB1501). Afterwashes,membranes
were incubated for 1 h with the appropriate HRP-conjugated secondary
antibody. The immunoreactive bands were detected by the enhanced
chemiluminescence method and intensities were quantiﬁed using the
ImageJ program.
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Cytochrome c is an essential component of the electron transport
chain in mitochondria transferring one electron from complex III to
complex IV. Its release to the cytoplasm is involved in initiation of cell
apoptosis. Cytosolic and mitochondrial cytochrome c concentrations
were measured using the double antibody sandwich ELISA kit (Enzo
Life Sciences, Belgium). Brieﬂy, HK-2 cells were treated with 1 μg/ml
LPS for 1 h or 6 h, harvested, suspended in HBSS at the ﬁnal concentra-
tion of 107 cells/ml and centrifuged at 500 ×g for 5 min. The pellet was
incubated with Digitonin Cell Permeabilization Buffer on ice for 5 min
and centrifuged at 500 ×g, 4 °C for 10 min. The supernatant containing
the cytosolic fraction of cytochrome c (fraction 1) was kept on ice
and the pellet was then incubated with RIPA Cell Lysis Buffer on ice
for 5 min. The resulting lysate was centrifuged at 5000 ×g, 4 °C for
10 min. The supernatant containing the mitochondrial fraction of cyto-
chrome c (fraction 2) was kept on ice. Both fractions 1 and 2were intro-
duced on a 96-well plate coated with a monoclonal antibody speciﬁc to
cytochrome c. The appropriate antibody, conjugate and substrate were
added in each well according to the kit protocol and the optical density
at 405 nmwas read on aMultiskanMicroplate Reader (Thermo scientif-
ic, Belgium). Concentrations of cytochrome c were calculated from a
standard curve.2.7. Measurement of complex IV activity
Mitochondrial complex IV catalyzes the terminal reaction of the
electron transport chain, the reduction of oxygen to water. It plays a
critical role in establishing the electrical membrane potential that ATP
synthase uses to synthesize ATP. The mitochondrial complex IV activity
was controlled in LPS-treatedHK-2 cells. After LPS treatment, HK-2 cells
were collected in ice cold PBS and centrifuged at 350×g, 4 °C for 10min.
The cellular pellet was resuspended into a small amount of isolation
buffer (300 mM D-Mannitol, 0.1% BSA, 250 μM EDTA, 10 mM HEPES,
pH 7.4). It was homogenized for 10 min with a Dounce homogenizer
and then centrifuged at 1500 g, 4 °C for 10 min. The supernatant,
containing the cell cytosol and mitochondria, was then centrifuged at
14000 ×g, 4 °C for 15 min. The cytosolic supernatant was kept and the
protein content was measured with a BCA protein assay kit (Sigma-
Aldrich, Belgium). Themitochondrial pellet was resuspended in storage
buffer (225 mM D-Mannitol, 75 mM sucrose, 125 μM EDTA, 10 mM Tris,
pH 7.4) and centrifuged twice at 14000 ×g, 4 °C for 15 min. At the end,
the preparation was resuspended in 100 μl of storage buffer and stored
at−80 °C until analysis.
The mitochondrial complex IV activity was analyzed using the cyto-
chrome c oxidase assay kit (Sigma-Aldrich, Belgium). This colorimetric
assay is based on the quantiﬁcation of the ferrocytochrome c absor-
bance decrease at 550 nm caused by its oxidation by complex IV. The
kinetics was performed on a Multiskan Microplate Reader (Thermo
scientiﬁc, Belgium).2.8. Measurement of ATP content by bioluminescence
The electron transport chain, together with ATP synthase, provides
the vast majority of cellular energy in the form of ATP. Its production
in renal cells under LPS stimulation was controlled by using a commer-
cially available luciferin–luciferase assay kit (Sigma-Aldrich, Belgium).
HK-2 cells were treated with 1 μg/ml LPS for 1 h or 6 h, washed twice
with PBS, harvested and lysed with the somatic cell ATP releasing re-
agent provided by the commercial kit. Luciferin substrate and luciferase
enzymewere added and bioluminescencewas assessed on a Fluoroskan
AscentMicroplate Fluorometer (Thermo scientiﬁc, Belgium).Whole cell
ATP contentwas determined by running an internal standard. The cellu-
lar ATP level was converted to a percentage of untreated cells.2.9. Confocal laser scanning microscopy for ﬂuorescence imaging
Different speciﬁc ﬂuorescent probes (all fromMolecular Probes, Life
Technologies, Belgium) were used to assess mitochondrial activity and
cellular oxidative stress. MitoTracker Green probe is sequestered by
functioning mitochondria and is capable of staining mitochondria re-
gardless of their polarization status; therefore it is considered as a struc-
tural dye [31,32]. The potentiometric ﬂuorescent dye TMREwas used to
control the mitochondrial membrane potential as it is known to accu-
mulate in themitochondrialmatrix driven by the electrochemical gradi-
ent [31,33]. DCF and MitoSOX Red were used to target oxidative stress
inside living cells as their oxidation by ROS was associated to green
and red ﬂuorescence respectively [31,34,35]. Cells were cultured on
glass coverslips in 6-well plates and then respectively incubated at
37 °C with 100 nM MitoTracker Green and 5 μM MitoSOX Red for
20 min or 20 nM TMRE and 20 μM DCF for 10 min. Furthermore, to
inhibit the complex I activity, HK-2 cells were incubated for 1 h with
rotenone which blocks NADH oxidation. Prior to microscopy experi-
ments, cells were washed three times with PBS and the coverslips
were mounted on a hydrostatic Attoﬂuor cell chamber (Invitrogen)
ﬁlled with prewarmed HBSS buffer.
Fluorescence imageswere performed using Leica SP5-AOBS confocal
laser scanningmicroscope (Leica, Germany) implemented at the Centre
de Photonique Biomédicale (CPBM) of Orsay (France). Images were ac-
quired using a 40×–1.25 numerical aperture oil immersion objective.
The size of the confocal images was 512 × 512 pixels recorded on 12
bits photomultiplier with a zoom value of 1×. An UV laser (364 nm)
was used as the excitation of endogenous NADH and its ﬂuorescence
was collected in the spectral range 420–480 nm. MitoTracker Green
and DCF ﬂuorescence were excited with the 488 nm wavelength of a
continuous argon laser and their ﬂuorescence was collected in the spec-
tral range 495–535 nm.MitoSOXRed and TMREwere excited at 516 nm
and 543 nm respectively and their ﬂuorescence was collected in the
spectral range 570–620 nm.
All confocal microscopy experiments were performed at least
3 times. ImageJ software was used to analyze the images, which were
false color coded for display.
2.10. Co-localization experiments
For co-localization experiments, cells were observed using a 63×–1.4
numerical aperture and the zoom was optimized according to the
Shannon–Nyquist theorem to obtain the best sampling regarding the
resolution of the confocal microscope [36]. Thus to decipher co-
localization of NADH and MitoTracker Green, we used a 7.03× zoom in
order to have the most appropriate lateral pixel size dxy = 68.57 nm
with a mean emission wavelength located at 480 nm. The step of the
z-stack was determined by the axial pixel size dz = 0.15 μm. For co-
localization experiments of MitoTracker Green and MitoSOX Red,
a 6.63× zoom was used in order to have a lateral pixel size dxy =
73.7 nm with a mean emission wavelength located at 516 nm still with
an axial pixel size dz = 0.15 μm.
Co-localization analysis was performed using JACoP v2.0, a plug-in
running under ImageJ software, developed by Bolte et Coredelières
[36]. The statistical method provides the Pearson coefﬁcient which
varies between−1 (exclusion) and +1 (total co-localization) and re-
ﬂects an unbiased co-localization of two ﬂuorescent probes as tested
by Costes' method [37,38]. In the present work, a Pearson coefﬁcient
N+0.5 was considered statistically signiﬁcant for co-localization of
two probes.
2.11. Flow cytometry analysis of mitochondrial activity
To control cell mitochondrial activity, ﬂow cytometry experiments
were performed using FACSCalibur ﬂow cytometer (Becton Dickinson)
equipped with a 20 mW argon ion laser tuned to 488 nm and a
Fig. 1. Induction of iNOS and •NO generation in LPS-treated HK-2 cells. A: Time course of
RT-PCR data showing induction of iNOS expression in HK-2 cells treatedwith LPS. B: Total
•NO generation by HK-2 cells treated with LPS measured by NO3−/NO2− production in cell
culture supernatants. L-NMMA (100 μM) was used as NOS-speciﬁc blocker. *, P b 0.05
compared to control cells; **, P b 0.005 compared to control cells; °°, P b 0.005 compared
to the 6 h LPS-treated cells.
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CellQuest software. After LPS exposure, HK-2 cells were washed twice
with PBS and incubated with 100 nM MitoTracker Green and 5 μM
MitoSOX Red for 20min. As for confocal microscopy, cells were washed
three times with PBS and resuspended in HBSS before ﬂow cytometry
analysis. The MitoTracker green ﬂuorescence (FL1) and the MitoSOX
Red ﬂuorescence (FL2) were collected through 532/45 and 590/35
band pass ﬁlters respectively. As samples were simultaneously stained
with two dyes, ﬂuorescence compensation was set up step by step in
order to avoid ﬂuorescence emission interferences. The order of magni-
tude of compensation parameters was FL1−5% FL2 and FL2−25% FL1
(determined on single staining samples).
2.12. Flow cytometry analysis of cell apoptosis
The externalization of phosphatidylserine was performed as
described before [39]. After LPS treatment, HK-2 cells were washed
with PBS, trypsinized and resuspended in HEPES buffer. Cells were
then stained as described by the manufacturer (Annexin-V-Fluos stain-
ing kit, Roche, Germany). Brieﬂy, 1% v/v Annexin-V-Fluorescein (ANN)
and 5% v/v propidium iodide (PI) were added to 106 cells and incubated
for 15min at room temperature. Analysis was donewith a FACSCanto II
ﬂow cytometer (Becton Dickinson) using a 488 nm excitation. The ANN
blue ﬂuorescence (FL1) and the PI yellow ﬂuorescence (FL2) were col-
lected through a 515/30 and 585/42 band pass ﬁlters respectively. A
minimum of 10,000 cells was analyzed for each measurement. Data ac-
quisition was performed using FACSDiva software. Living cells are char-
acterized by both negative ﬂuorescence of ANN and PI (ANN−/PI−),
apoptotic cells by a positive ﬂuorescence of ANN and by either a positive
or a negative ﬂuorescence of PI (ANN+/PI− or ANN+/PI−) and
necrotic cells by a negative ﬂuorescence of ANN and a positive ﬂuores-
cence of PI (ANN−/PI+).
2.13. Statistical analysis
Data were represented asmean± SD. The paired Student t-test was
used to compare two conditions (without and with LPS treatment)
using the original data. P values less than 0.05 were considered statisti-
cally signiﬁcant.
3. Results
3.1. LPS induces iNOS expression and •NO generation in HK-2 cells
Since induction of iNOS occurs in the kidney during sepsis [15,40]
and that its derivative •NO acts as a competitive substrate with O2
for the binding site of complex IV [41,42], we have investigated their
role in the modulation of renal cell respiration. Fig. 1A shows a time-
dependent induction of iNOS mRNA in HK-2 cells treated with LPS.
iNOS expression began to change after 1 h of treatment and increased
three times at 6 h compared to control cells (P b 0.0001, n = 5).
This variation in iNOS mRNA expression was correlated to an in-
crease in •NO production along time (Fig. 1B), reaching 50% at 6 h
(P b 0.0001, n = 4) and 70% at 24 h (P b 0.0001, n = 4) compared to
control cells (n=6). Importantly, the rise in •NOproduction stimulated
by LPS was blocked by the addition of a NOS inhibitor (L-NMMA),
strongly suggesting the induction of this radical from the active iNOS.
The relatively low level of nitrite detected in this case suggests a possi-
ble basal production of •NO by NOS in control cells, as L-NMMA is a
relatively non-selective inhibitor of all NOS isoforms.
3.2. ROS are also mediators in the propagation of LPS stress
ROS aremajormediators in inﬂammatory processes. Their production
arises from the activity of numerous enzymes, including NADPH oxidase,
•NO synthase, xanthine oxidase, and themitochondrial respiratory chain.In this part,we investigated the possible role ofNOX-4 in the LPS-induced
intracellular oxidative stress. As shown in Fig. 2A, NOX-4 expression
was already up-regulated from 3 h of LPS treatment: 1.33 ± 0.28-fold
(P = 0.008, n = 7) compared to control cells and was maintained over-
time: 1.34 ± 0.28-fold (P = 0.008, n = 7) and 1.36 ± 0.30-fold (P =
0.006, n = 7) after 6 h and 24 h of treatment respectively. However,
this up-regulation was blocked when cells were pre-treated 2 h with
20 μM DPI, a NOX inhibitor, before LPS addition (P = 0.03, n = 3).
This increase inNOX-4 expressionwas accompanied by an increase in
cytosolic ROS production. After 6 h and 24 h of LPS treatment, a signiﬁ-
cant rise in the DCF ﬂuorescence signal intensity (P b 0.0001 and P =
0.001 respectively, n = 4) (Fig. 2B) and in the formazan absorbance
(P = 0.02 in both cases, n = 6) (Fig. 2C) was observed compared
to the control cells, indicating an overproduction of cellular ROS (as re-
vealed by DCF ﬂuorescence) and particularly superoxide anion radicals
O2•− (as indicated by the NBT test).
When GSH and EBS, respectively ROS and peroxynitrite scavengers,
were added to LPS-treated cells, the DCF ﬂuorescence returned to a
value comparable to that obtained for the untreated cells (P b 0.0001
and P = 0.0004 respectively, n = 3) (Fig. 2B). The same observations
were made in HK-2 cells for the formazan absorbance when GSH
and DPI were added to cells upon LPS treatment (P = 0.04 and P =
0.02 respectively, n = 6) (Fig. 2C).3.3. LPS effects on HK-2 cell mitochondria network
Theﬂuorescence image (Fig. 3A-a) shows thatmitochondria in HK-2
cells are organized in a network with an ovoid-shaped and a multi-
Fig. 2. Induction of NOX-4 and ROS generation in LPS-treated HK-2 cells. A: Time course of NOX-4 and actin expression in LPS-treated HK-2 cells measured bywestern blot. The histogram
represents the densitometry analysis of NOX-4 expression relative to actin inHK-2 cells. B: Fluorescence intensity confocal images and their corresponding quantiﬁcation of the DCF probe
(570–620 nm) in HK-2 cells without treatment (a); after 6 h of LPS treatment (b); after 6 h of LPS treatment in presence of 100 μM GSH (c) or 10 μM EBS (d). Two hundred cells were
analyzed in 3–4 independent experiments. C: Evolution of the formazan absorbance over time inside HK-2 cells. GSH (100 μM) and DPI (10 μM) were used as antioxidants and NADPH
oxidase inhibitors respectively. *, P b 0.05 compared to control cells; **, P b 0.005 compared to control cells; °, P b 0.05 compared to the 6 h LPS-treated cells; °°, P b 0.005 compared to
the 6 h LPS-treated cells.
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LPS treatment (Fig. 3A-b). The 2D quantiﬁcation of the ﬂuorescence
intensity images (Fig. 3B) did not reveal signiﬁcant variation in the mi-
tochondrial ﬂuorescence signal after LPS treatment. This was conﬁrmed
by ﬂow cytometry analysis (Fig. 3C) that did not show any variation in
the total amount of mitochondria per cell after LPS treatment whatever
the incubation time.
3.4. LPS effects on the mitochondrial respiratory chain activity
The redox state of mitochondria was ﬁrst controlled by monitoring
the ﬂuorescence intensity of the coenzyme nicotinamide adenine dinu-
cleotide. Its reduced form (NADH) emits ﬂuorescence in the 420–
480 nm range while its oxidized form (NAD+) is non-ﬂuorescent. It is
well known that in this spectral range, the cell autoﬂuorescence emission
is provided both from the mitochondrial NADH and the cytoplasmic
NAD(P)H [43]. Thus we controlled that the emission collected in the
420–480 nm range originated essentially from the mitochondria of
HK-2 cells. Indeed, Fig. 4A shows that NADH and MitoTracker Green
ﬂuorescence spectra overlapped (cyan points) with a Pearson coefﬁcientof 0.75±0.09 in control cells (Fig. 4A-a) andof 0.75±0.07 in LPS-treated
cells (Fig. 4A-b).
We then controlled that our experimental set-up allowed us to
quantify a displacement of NAD+/NADHequilibrium by using rotenone,
an inhibitor of the mitochondrial electron transport chain that acts on
the complex I activity. As illustrated in Fig. 4B and C, the NADH ﬂuores-
cence intensity signiﬁcantly increased and was correlated with both an
accumulation of the reduced state of the coenzyme and an inhibition of
complex I activity. However, under LPS stimulation, no variation in the
intensity of NADH ﬂuorescence signal was observed during 24 h in
HK-2 cells (Fig. 4B and C).
We further assessed the LPS effects on the electronﬂux along themi-
tochondrial respiratory chain by loading HK-2 cells withMitoSOX red, a
mitochondrial ROS generation indicator (Fig. 5A and B). As revealed by
ﬂow cytometry experiments (Fig. 5B), MitoSOX Red oxidation was sig-
niﬁcantly increased by 15% in LPS-treated cells only at 6 h (P = 0.03,
n = 4) and 24 h (P = 0.04, n = 6) following exposure. Importantly,
MitoSOX Red co-localized almost totally with MitoTracker Green probe
(yellow points, Fig. 5A) with a Pearson coefﬁcient of 0.91± 0.03 in con-
trol cells (Fig. 5A-a) and of 0.92 ± 0.04 in LPS-treated cells (Fig. 5A-b),
Fig. 3. Effect of LPS treatment on mitochondrial organization and quantiﬁcation in HK-2 cells. A: Fluorescence intensity confocal images of the distribution of the MitoTracker dye (495–
535 nm) in HK-2 cells without treatment (a) and after 6 h of LPS treatment (b). B and C: Evolution of the ﬂuorescence signal intensity of the MitoTracker Green probe over time inside
HK-2 cells measured by confocal microscopy (110 cells were analyzed in 3 independent experiments) and ﬂow cytometry respectively.
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MitoSOX red ﬂuorescence was detected within control cells, suggesting
a basal production of ROS by HK-2 cell mitochondria (Fig. 5A-a). These
ROS surely come from byproducts of the normal cell metabolism [44].Fig. 4.Monitoring mitochondrial redox state by NADH autoﬂuorescencemeasurement in HK-2
network in HK-2 cells without treatment (a) and after 6 h of LPS treatment (b). The blue and g
length of NADH andMitotracker Green respectively. The sites of co-localization appear in cyan.
confocal images of NADH (420–480 nm) in HK-2 cells without treatment (a); after 1 h of 1 μM
autoﬂuorescence signal intensity over time inside HK-2 cells measured by confocal microscop
compared to control cells.Cytochrome c has a major role in transferring electrons from
complex III to complex IV. Its release in the cytosol could be used as
an indicator of the respiratory chain dysfunction and is the primary
step leading to cell apoptosis. Thereby, after LPS exposure, the amountcells treatedwith LPS. A: Confocalmicroscopy imaging (7.03× zoom) of themitochondrial
reen pseudo-colors of ﬂuorescence intensity emission correspond to the emission wave-
One hundred cells were analyzed in 4 independent experiments. B: Fluorescence intensity
rotenone treatment (b); after 6 h (c) and 24 h (d) of LPS treatment. C: Evolution of NADH
y. One hundred and ﬁfty cells were analyzed in 4 independent experiments. **, P b 0.005
Fig. 5. Inhibitory effects of LPS onmitochondrial respiratory chain activity. HK-2 cells were treatedwith LPS and its impact on complexes III, IV and Vwas analyzed. A: Confocalmicroscopy
imaging (6.63× zoom) of the mitochondrial network in HK-2 cells without treatment (a) and after 6 h of LPS treatment (b). The red and green pseudo-colors of ﬂuorescence intensity
emission ﬁt to the emission wavelength of MitoSOX Red and Mitotracker Green respectively. The sites of co-localization appear in yellow. Twenty cells were analyzed in 2 independent
experiments. B: Evolution of the ﬂuorescence signal intensity of theMitoSOX Red probe over time inside HK-2 cells measured by ﬂow cytometry. C: Respectively, cytosolic andmitochon-
drial cytochrome c concentrations determined by ELISA kit assay. D: Analysis of complex IV activity in LPS-treated HK-2 cells. 1400W and EBS were used as human iNOS-speciﬁc blocker
and as a scavenger of peroxynitrite respectively for LPS-treated cells during 6 h. E: Determination of cellular ATP level in LPS-treatedHK-2 cells. TreatmentwithH2O2was used as a positive
control group. *, P b 0.05 compared to control cells; **, P b 0.005 compared to control cells; °, P b 0.05 compared to the 6 h LPS-treated cells.
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determined by ELISA kit assay (Fig. 5C). The cytosolic concentration of
cytochrome c was signiﬁcantly increased after 6 h and 24 h of LPS treat-
ment. Indeed, it reached 7.8 ± 5.1 × 104 pg/107 cells (P= 0.05, n = 4)
and 4.2 ± 2.4 × 104 pg/107 cells (P = 0.08, n = 3) in the 6 h and 24 h
LPS-treated cells respectively, compared to 1.3 ± 1.2 ×104 pg/107 cells
in control cells (n = 4).
Correlatively, complex IV activity dropped by 55% in HK-2 cells
treated with LPS for 6 h (P = 0.001, n = 4) and 24 h (P = 0.01, n =
4). However, when the antioxidant 1400W, a selective inhibitor of
human iNOS [45], or EBS was also added with LPS, complex IV activity
showed a signiﬁcant slight recovery (Fig. 5D). It must be noted that
1400W had more pronounced effect than EBS. Indeed, the cytochrome
c oxidase activity increased from 5.2 ± 0.7 mU/mg at 6 h LPS treatment
to 9.4 ± 3.1 (P = 0.04, n = 4) and 7.1 ± 102 (P = 0.04, n = 4) in the
presence of 1400W and EBS respectively (Fig. 5D).
Importantly, ATP synthase activity was also inhibited by the LPS
treatment of HK-2 cells, as revealed by the bioluminescent kit
(Fig. 5E). A 30% fall in ATP production was observed after 6 h oftreatment (P = 0.004, n = 4) and remained lower after 24 h of treat-
ment (P = 0.0007, n = 6) by comparison to the untreated cells.
3.5. LPS induces mitochondrial membrane depolarization
Alteration of the activity of mitochondrial complexes might induce
some perturbation in the electrical membrane potential created by the
proton gradient across themitochondrial innermembrane and required
for ATP synthase to convert ADP to ATP.
In our experimental conditions, variations in the electrical mem-
brane potential were detected as changes in TMRE ﬂuorescence intensi-
ty, a membrane depolarization being correlated to TMRE ﬂuorescence
decrease [46]. This was observed after cell treatment by LPS, with a
drop of the TMRE ﬂuorescence signal of 60% at 6 h (Fig. 6A-b and B)
that remained low at 24 h (Fig. 6A-c and B). This fall is clearly an indica-
tor of mitochondrial dysfunction. However, when cells were both
exposed to LPS and different antioxidants, 1400W, GSH, or EBS, the
TMRE ﬂuorescence signal intensity was not modiﬁed referring to the
untreated cells (Fig. 6B).
Fig. 6. Detection of mitochondrial membrane depolarization. A: Fluorescence intensity confocal images of the TMRE probe (570–620 nm) in HK-2 cells without treatment (a); after 6 h
(b) and 24 h (c) of LPS treatment; after 6 h of LPS treatment in presence of 10 μM 1400W (d), 100 μM GSH (e) or 10 μM EBS (f). B: Evolution of the ﬂuorescence signal intensity of the
TMRE probe over time insideHK-2 cellsmeasuredby confocalmicroscopy. 1400W(10 μM), GSH (100 μM)and EBS (10 μM)were used as selective inhibitor of human iNOS, as antioxidants
and as scavengers of peroxynitrite respectively. Twohundred and ten cellswere analyzed in 4 independent experiments. **, P b 0.005 compared to control cells; °, P b 0.05 compared to the
6 h LPS-treated cells.
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The cytochrome c release and the mitochondrial membrane poten-
tial dissipation are signs of cells undergoing apoptosis. Thereby, analysis
of the percentage of necrosis/apoptosis of LPS-treated HK-2 cells was
performed by following the intensity of ANN/PI labeling by ﬂow cytom-
etry (Fig. 7). It appeared that LPS did not induce HK-2 cell mortality
during the ﬁrst 24 h of treatment as the proportion of viable cells was
maintained (90%). However, the proportion of apoptotic cells was sig-
niﬁcantly increased after 48 h (40%) and 72 h (55%) of LPS treatment.4. Discussion
Themechanismof sepsis-induced kidney injury is poorly understood,
in particular the link between the inﬂammation process and renal
cell dysfunction has not been yet well established. However, for some
years, it has become increasingly clear that oxidative stress and mito-
chondrial dysfunction are implicated in the development of sepsis-induced kidney injury but the precise pathophysiological mechanisms
remain elusive [47,48]. In particular, it is not certain whether mitochon-
drial dysfunction is the primary event leading to oxidative stress and
with subsequent mitochondrial damage or, conversely, whether oxida-
tive stress contributes tomitochondrial dysfunction [24,25]. In a previous
study, we have demonstrated that the basal respiration of renal HK-2
cells subjected to the LPS endotoxin was altered and presented a strong
decrease in the oxygen consumption rates [11]. This cell metabolic
down regulation strongly suggests an alteration of cellular respiration,
with mitochondria probably playing a prominent role. In this context,
the present study has employed HK-2 cells as a cell model system and
has aimed to elucidate the mechanism of cell renal respiration dysfunc-
tion under LPS stress.
The present study reveals for the ﬁrst time that the intracellular
oxidative stress occurs before mitochondrial dysfunction in renal cells
subjected to LPS stimulation. Indeed, our study reveals that the activa-
tion of the two enzymes, NADPH oxidase 4 (NOX-4) and inducible NO
synthase (iNOS), comes out as soon as the renal cells were stressed by
LPS. The rapid induction of NOX-4 and iNOS overexpression gives rise
Fig. 7. Effect of LPS on HK-2 cells mortality. Percentage of living (□), apoptotic (●) and
necrotic (▲) cells after LPS treatment.
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ly, resulting in a primary redox state. To our knowledge, it is the ﬁrst
time that NADPH oxidase-derived superoxide contribution is highlight-
ed in tubular cell injury.
Moreover, the simultaneous production of O2•− and •NO in the cel-
lular cytosol could certainly stimulate the formation of ONOO−, as its
formation rates is competitive to that of cytoplasmic SOD. This was con-
ﬁrmed by the signiﬁcant increase in DCF ﬂuorescence signal, blocked
when using antioxidants such as L-glutathione and ebselen, revealing
further reactions of O2•− to form its derivatives •OH and ONOO−. In a
previous study, the group of Mayeux et al. has already pointed out, in
an in vitromodel of renal cells treated with septic serum, the induction
of intracellular iNOS expression and the production of •NO and its by-
product ONOO−, but the mechanism involved was not fully explained
and the oxidative stress appeared to be a consequence of mitochondrial
dysfunction [15,49].
Undoubtedly, cytosolic ROS (O2•−, •OH) and RNS (•NO, ONOO−)
overproductionmay exert deleterious effects on the function and integ-
rity of mitochondria with further disruption of cellular oxidative ATP
production [23,50]. In particular, iNOS-derived •NO acts as a competi-
tive substrate with O2 for the binding site in cytochrome c oxidase
(complex IV) [42]. Because of its relative stability, ONOO− can diffuse
through mitochondrial compartments and undergo cytotoxic reactions
with complexes I, IV and V causing their inactivation [51–54]. At
the same time, O2•− could react with and stimulate ATP-sensitive K+
channels in the inner mitochondrial membrane [55] and •OH could un-
dergo mitochondrial membrane lipid peroxidation [56]. In the present
experimental renal model, confocal and ﬂow cytometry experiments
have demonstrated that the functional activity of mitochondria was
disrupted as the LPS treatment induced a signiﬁcant fall inmitochondri-
al membrane polarization. However, this modiﬁcation did not arise
with mitochondrial spatial disorganization or total amount of mito-
chondrial per cell loss.
We therefore tried to characterize the electron transport chain
dysfunction. Complex I activity was explored by monitoring NADH
mitochondrial ﬂuorescence. This complex, which catalyzes the transfer
of electrons from NADH to coenzyme Q did not seem to be affected by
LPS treatment. In contrast, cytochrome c oxidase activity was signiﬁ-
cantly inhibited by LPS treatment and was accompanied by the release
of cytochrome c in the cytosol. The oxidative phosphorylation dysfunc-
tion is thus augmented due to interruption of electron ﬂux in the elec-
tron transport chain. The involvement of inhibition of complexes I
and/or IV in mitochondrial dysfunction symptoms seemed to be depen-
dent on the tissue that undergoes stress. In animal models of sepsis,complex I remained intact and complex IV was inhibited in liver cells
as we observed for the renal cells while complex I and not complex IV
was inhibited in brain cells [23,57].
The use of antioxidant treatment prevented inhibition of the respira-
tory chain complexes, especially by restoring mitochondrial membrane
polarization necessary for oxidative phosphorylation. In particular, the re-
covery of cytochrome c oxidase activity was more important when using
1400W rather than ebselen. The former blocks simultaneously the effects
of •NO and ONOO−while the latter one only affects the ONOO− produc-
tion. Thus, both •NO and ONOO− seemed to play amajor role in the prop-
agation of LPS stress onmitochondria by inhibiting cytochrome c oxidase.
Interestingly, an overproduction ofmitochondrial ROSwas observed
probing by MitoSOX ﬂuorescence, revealing an electron leakage from
the electron transport chain. Mitochondria are a major source of intra-
cellular ROS, which are generated as a result leakage of unpaired elec-
trons from complexes I and III and their subsequent reaction with
oxygen [19]. As complex I seemed not to be affected by LPS, it can be
reasonably suggested that electrons escaped mostly from complex III.
However, this mitochondrial production of ROS provides a plausible ex-
planation for not having detected the change in the redox state of
NADH. The coenzyme may be oxidized by ROS byproducts, such as
peroxyl and thyl radicals [56], and may not show the expected increase
in its ﬂuorescence when complex I is inhibited. The mitochondrial gen-
eration of ROS (mainly O2•−) supposes also mitochondrial production
of ONOO− that participates both in the inhibition of cytochrome c
oxidase and in the release of cytochrome c in the cytosol as reported
elsewhere [54]. Overall, dysfunction of the electron transport chain
generated thus more ROS enhancing therefore oxidative stress and mi-
tochondrial damage.
The ﬂow of electrons between respiratory mitochondrial complexes
I–IV provides energy to transfer protons across the inner membrane
from the matrix to the intermembrane space. The resulting mitochon-
drial membrane potential is not only essential for ATP production but
also essential to maintain the mitochondrial homeostasis. The overall
LPS-induced oxidative stress and its cumulative effect on electron trans-
port chain enzyme complexes, mentioned in the proposed mechanism
scheme (Fig. 8), have resulted in a fall in the mitochondrial membrane
potential and consequently in a sharp decrease of cellular ATP level.
The dissipation of the proton gradient induced an uncoupling between
the electron transport chain and the ATP energy production. Altogether,
the decrease in cytochrome c oxidase activity and in ATP production is
in accordancewith ourﬁrst results showing thatHK-2 cells exhibit a de-
creased oxygen consumption rate when treated with LPS [16]. In this
way, a major mechanism that could explain the inability of the renal
cells to use the available oxygen for ATP production during inﬂamma-
tion is likely to be an interruption in oxidative phosphorylation within
mitochondria, mechanism known as cytopathic hypoxia [8,58].
Finally, the release of cytochrome c induced by the mitochondrial
membrane depolarization, together with the cellular ROS generation,
brought about apoptosis that was observed in HK-2 cells at the later
stage of LPS treatment. This cell death is anothermechanism that should
be taken into account in the occurrence of kidney injury [59].
5. Conclusion
In summary, this work supports the hypothesis that the inﬂamma-
tory response inherent to sepsis must be considered as a direct mecha-
nism of AKI. Under inﬂammatory conditions, mitochondria play a
central role in the intracellular events, the reduction in cellular oxygen
utilization being related to defect of cytochrome c oxidase activity. The
renal injury is thus associated to a signiﬁcant reduction in the capacity
to generate ATP supporting the concept of mitochondrial-based cyto-
pathic hypoxia as the main mechanism.
This investigation has also provided key features on the relationship
between oxidative stress and mitochondrial respiratory chain activity
defects. Firstly, it has revealed that the intracellular oxidative stress is
Fig. 8. Proposedmechanism of cytopathic hypoxia according to our experimental results. LPS treatment resulted in a cytosolic oxidative stress induced by the overexpression ofNOX-4 and
iNOS. This primary oxidant state interruptedmitochondrial oxidative phosphorylation by reducing cytochrome c oxidase activity. As a consequence, disruptions in the electron transport
and the proton pumping across themitochondrial innermembrane occurred, leading to a decrease of themitochondrial membrane potential, a release of apoptotic-inducing factors and a
depletion of cellular ATP production from ATP synthase.
1799C. Quoilin et al. / Biochimica et Biophysica Acta 1837 (2014) 1790–1800an event that appears before mitochondrial dysfunction in renal cells
subjected to LPS stimulation. This primary redox state is notably due
to the activation of two enzymes, the NADPH oxidase 4 and the induc-
ible NO synthase (iNOS). To our knowledge, our model reveals for the
ﬁrst time the role of NADPH oxidase-derived cytosolic ROS in triggering
tubular cell injuries. Secondly, this study have shown that mitochondria
are ﬁrst target of ROS than become producer of ROS. It seems thus that a
mechanism of ROS-induced ROS formationmight be amain cause of the
mitochondrial dysfunction.
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